Bombay Treat Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-12-2024
- Paid Up Capital ₹ 0.10 M
as on 24-12-2024
- Company Age 2 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
About Bombay Treat
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jaiprakash Kulkarni and Raviraj Kulkarni serve as directors at the Company.
- CIN/LLPIN
U15490MH2022PTC380880
- Company No.
380880
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Apr 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bombay Treat?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raviraj Kulkarni  | Director | 19-Apr-2022 | Current |
| Jaiprakash Kulkarni | Director | 19-Apr-2022 | Current |
Financial Performance of Bombay Treat.
Bombay Treat Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Bombay Treat?
Unlock access to Bombay Treat's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Kokan Plantation (Opc) Private LimitedActive 3 years 7 months
Jaiprakash Kulkarni is a mutual person
- Pharma Search Ayurveda Private LimitedActive 29 years 3 months
Jaiprakash Kulkarni and Raviraj Kulkarni are mutual person
- Pharmasearch Agricultural Research Private LimitedActive 11 years 2 months
Jaiprakash Kulkarni and Raviraj Kulkarni are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bombay Treat?
Bombay Treat has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bombay Treat, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bombay Treat's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
